Abstract
The platelets, formed by fragmentation from the megakaryocytes in the bone marrow, circulate in the blood and play a significant role in normal haemostasis as well as in pathological processes such as thrombosis, atherosclerosis, inflammation and immune rejection. Within the platelet are secretory storage vesicles of both dense and a granules containing respectively lower and higher molecular weight species. The contents of the a granules are largely proteins and include not only the familiar plasma proteins such as albumin and fibrinogen, but also a large proportion of unique proteins that have been referred to as platelet-specific granule proteins. Since normal plasma contains only low levels of these latter proteins, their assay measurement in plasma ex vivo constitutes a valuable method of measuring platelet activation and secretion as it occurs in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albala MM, Levine PH (1984) Platelet factor 4 and beta-thromboglobulin in moya-moya disease. Am J Pediatr Haematol Oncol. 6: 96–99
Almondhiry H, Pierce WS, Pennock JL (1985) Platelet release in coronary heart disease - effect of antiplatelet drugs and coronary artery bypass graft. J Lab Clin Med. 105: 397–402
Andrassy K, Deppermann D, Ritz E, Koderisch J, Seelig H (1980) Different effects of renal failure on beta-thromboglobulin and high affinity platelet factor 4 (HA-PF4) concentrations. Thromb Res. 18: 469–175
Aren C, Fedderson K, Tegernilsson AC, Radegran K (1983) Effects of prostacyclin infusion of platelet release during extracorporal circulation. Int J Microcirc. 2: 268–269
Arocha-Pinango CL, Ojeda A, Lopez G, Garcia L, Linares J (1985) Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases. Acta Obstet Sci. 2: 115–120
Aushri Z, Berginer V, Nathan I, Dvilansky A (1983) Plasma thromboglobulin and platelet aggregation index in transient ischemic attack - effect of aspirin and dipyridamole therapy. Int J Clin Pharmacol Ther Toxicol. 3: 339–342
Baele G, Rottiers R, Rubens R, Priem H (1982) Effect of ticlopidine on plasma beta-thromboglobulin and platelet factor 4 levels in diabetes mellitus - preliminary finds. Haemos- tasis. 12: 138
Baenziger NL, Brodie GN, Majerus PW (1971) A thrombin sensitive protein of human platelet membranes. Proc Natl Acad Sci USA. 68: 240–243
Barber AJ, Kaserglanzmann R, Jakabova M, Luscher E (1972) Characterization of a chon- droitin 4-sulphate proteoglycan carrier for heparin neutralizing activity (platelet factor 4) released from human blood platelet. Biochim Biophys Acta. 286: 312–329
Begg GS, Pepper DS, Chesterman CN, Morgan FJ (1978) Complete covalent structure of human ßthromboglobulin. Biochemistry. 17: 1739–1744
Belch JJF, Greer I, McLaren M, Saniabadi AR, Miller S, Sturrock RD, Forbes CD (1985) The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers: a potential treatment for Raynaud’s syndrome. Scot Med J. 30: 124
Bern MM, Green J (1982) Effect of sulfinpyrazone upon antithrombin III and platelet factor 4 in chronic renal failure. Thromb Res. 27: 457–465
Berrettini M, Parise P, Costantini V, Grasselli S, Nenci GG (1985) Platelet activation in psoriasis. Thromb Haemost. 53: 195–197
Blattler W, Furrer K, Schriber K, Kofmehl R, Massini C (1981) Platelet proteins during and after prostacyclin therapy for lower limb ischaemia: suggestion of a rebound platelet activation. Vasa. 10: 261–263
Blattler W, Diener R, Haeberli A, Straub PW (1984) Plasma levels of beta-thromboglobu- lin and platelet factor 4 in peripheral vascular disease. Vasa. SI2:75–80
Bock PE, Luscombe M, Marshall SE, Pepper DS, Holbrook JJ (1982) The effect of concentrations and ionic strength on the aggregation of ß-thromboglobulin. Thromb Res 25: 169 - 172
Bolton AE, Ludlam CA, Moore S, Pepper DS, Cash JD (1976 a) Three approaches to the radioimmunoassay of human ß-thromboglobulin. Br J Haematol. 33: 233–238
Bolton AE, Ludlam CA, Pepper DS, Moore S, Cash JD (1976 b) A radioimmunoassay for platelet factor 4. Thromb Res. 8: 51–58
Borsey DQ, Prowse CV, Gray RS, Dawes J, James K, Elton RA, Clarke BF (1984) Platelet and coagulation factors in proliferative diabetic retinopathy. J Clin Pathol. 37:659– 664
Bowenpope DF, Ross R (1985) Methods for studying the platelet derived growth factor receptor. Methods Enzymol. 109: 69–100
Bowenpope DF, Malpass TW, Foster DM, Ross R (1984) Platelet derived growth factor in vivo - levels, activity and rate of clearance. Blood. 64: 458–169
Brindley LL, Sweet JM, Goetzl EJ (1983) Stimulation of histamine release from human basophils by human platelet factor 4. J Clin Invest. 72: 1218–1223
Brown TR, Ho TTS, Walz DA (1980) Improved radioimmunoassay of platelet factor 4 and beta-thromboglobulin in plasma. Clin Chim Acta. 101: 225–233
Buccianti G, Pogliani E, Miradoli R, Colombi MA, Valenti G, Lorenz M, Polli EE (1982) Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemo-dialysis - a possible role for a short acting inhibitor of platelet aggregation. Clin Nephrol. 18: 204–208
Bugiardini R, Chierchia S, Roskovec A, Wild S, Lenzi S, Maseri A (1982) Response of platelet release factors and aggregation to catheter induced activation and prostacyclin infusion in man. Clin Sci. 63: P73
Busch C, Dawes J, Pepper DS, Wasteson A (1980) The binding of PF4 to cultured human umbilical vein endothelial cells. Thromb Res. 19: 129–137
Cade JF, Doyle DJ, Chesterman CN, Morgan FJ, Rennie GC (1982) Platelet function in coronary artery disease: effects of coronary surgery and sulfinpyrazone. Circulation. 66: 29–32
Chesebro JH, Fuster V, Pumphrey CW, McGoon DC, Pluth JR, Puga FJ, Orszulak TA, Piehler JM, Schaff HY, Danielson GK (1981) Combined warfarin platelet inhibitor antithrombotic therapy in prosthetic heart valve replacement. Circulation. 64: 76
Ciaglowski RE, Snow JW, Walz DA (1981) Bovine platelet antiheparin protein–platelet factor 4. Ann NY Acad Sci. 370: 668–679
Clezardin P, McGregor JL, Manach M, Robert F, Dechavanne M, Clemetson KJ (1984) Isolation of thrombospondin released from thrombin stimulated human platelets by fast protein liquid chromatography on an anion exchange Mono-Q chain. J Chroma- togr. 296: 249–256
Contant G, Gouault-Heilmann M, Martinoli JL (1983) Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipy- ridamole-CTAD mixture. Thromb Res. 31: 365–374
Cooke ED, Bolton AE, Levack B (1981) Thromboglobulin levels in postoperative deep vein thrombosis. Lancet. 2: 1427
Cordopatri F, Boncinelli S, Marsili M, Lorenzi P, Fabbri LP, Paci P, Salvadori M, Morfini M, Cinotti S, Casparini P (1982) Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure - preliminary observations. Int J Artif Organ. 5: 243–247
D’Andrea G, Cananzi D, Toldo M, Cortelazzo S, Ferro-Milone F (1983) Platelet behaviour in classic migraine: responsiveness to small doses of aspirin. Thromb Haemost. 49: 153
Davi G, Novo S, Gullotti A, Avellone G, Sofia MA, Strano A (1984) Sulfinpyrazone and platelet function in hypertensive patients. Thromb Haemost. 51: 413
Davis JW, Hartman CR, Shelton L, Ruttinger HA (1983) Effect of tobacco smoking on release of platelet specific proteins. Clin Res. 31: A768
Davis LE, Castor CW, Tinney FJ, Anderson B (1985) Preparation and characterisation of antibodies with specificity for the amino-terminal tetrapeptide sequence of the platelet derived connective tissue activating peptide-III. Biochem Int 10: 395–104
Dawes J, Smith RC, Pepper DS (1978) The release distribution and clearance of human ß-thromboglobulin and platelet factor 4. Thromb Res. 12: 851–861
Dawes J, Pumphrey CW, McLaren KM, Prowse CV, Pepper DS (1982) The in vivo release of human platelet factor 4 by heparin. Thromb Res. 27: 65–76
Dawes J, Clemetson KJ, Gogstad GO, McGregor J, Clezardin P, Prowse CV, Pepper DS (1983) A radioimmunoassay for thrombospondin used in a comparative study of thrombospondin, ß-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res. 29: 569–581
Dawes J, Miller WR, Brown K (1985) Thrombospondin in milk and other breast secretions; a new marker for breast cyst classification. Thromb Haemost 54: 64
Deboer AC, Han P, Turpie AGG, Butt R, Zielinski A, Genton E (1981) Plasma and urine ß-thromboglobulin concentration in patients with deep vein thrombosis. Blood. 58: 693–698
Deboer AC, Genton E, Turpie AGG (1982) Chemistry, measurement and clinical significance of platelet specific proteins. CRC Crit Rev Lab Sci. 18: 183–211
Deboer AC, Han P, Turpie AGG, Butt R, Gent M, Genton E (1983) Platelet tests and antiplatelet drugs in coronary artery disease.Circulation. 67: 500–504
Ditter H, Heinrich D, Matthias FR, Sellmann-Richter R, Wagner WL, Hehrlein FW (1983) Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of ß-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin Fla and heparin. Thromb Res. 32: 393–108
Douglas JT, Blarney SL, Lowe GDO, Carter DC, Forbes CD (1985) Plasma beta-throm- boglobulin, fibrinopeptide A and B/715-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment. Thromb Haemost. 53: 235–238
Duncan A, Depratti VJ, George RR (1981) Elevated ß-thromboglobulin levels associated with smoking and oral contraceptive agents in normal healthy women. Thromb Res. 21: 425–430
Fabris F, Randi ML, Crociani ME, Manzoni S, Tonin P, Dezanche L, Cella G, Girolami A (1983) Platelet specific proteins in patients with transient ischemic attacks - effects of anti-platelet drugs. Ric Clin Lab. 13: 437–42
Fabris F, Randi ML, Casonato A, Zanon RDB, Bovicini P, Girolami A (1984) Clinical significance of beta-thromboglobulin in patients with high platelet count. Acta Haematol. 71: 32–38
Fabris F, Luzzatto G, Girolami A (1985) The value of ß-TG/PF4 ratio in patients with high platelet count. Thromb Haemost 53: 288
Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA (1981) Studies of human platelet alpha-granule release in vivo. Blood. 58: 607–618
Fitchett D, Toth E, Gilmore N, Ehrman M (1983) Platelet release of beta-thromboglobulin within the coronary circulation during cold pressor stress. Am J Cardiol. 52: 727–730
Flicker W, Milthorpe BK, Schindhelm K, Odell RA, McPherson J, Farrell PC (1982) Platelet factor release following heparin administration and during extracorporeal circulation. Trans Am Soc Artif Intern Organs 28: 431–436
Gartner TK, Walz DA (1983) TFP inhibits the expression of the endogenous platelet lectin and secretion of alpha-granules. Thromb Res. 29: 63–74
Ginsberg MH, Hoskins R, Sigrist P, Painter RG (1979) Purification of a heparin neutralizing protein from rabbit platelets and its homology with human platelet factor 4. J Biol Chem. 254: 2365–2371
Goetzl EJ, Brindley LL, Sweet JM, Handin RI (1983) Unique mechanism of stimulation of human basophils by platelet factor 4. Clin Res. 31: A457
Handin RI, McDonough M, Lesch M (1978) Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med. 91: 340–349
Hay CRM, Durber AP, Saynor R (1982) Effect of fish oil on platelet kinetics in patients with ischaemic heart disease. Lancet. 1: 1269–1272
Heldin CH, Westerman B, Wasteson A (1981) Demonstration of an antibody against platelet derived growth factor. Exp Cell Res. 136: 255–261
Holan J, Kubisz P, Cronberg S, Parizek M (1984) Platelet function studies in diabetics with beta-thromboglobulin (beta-TG) platelet factor 4 (PF4) and thromboxane-B2 (TXB2) RIA assay. Eur J Nucl Med. 9: A75
Hope W, Martin TJ, Chesterman CN, Morgan FJ (1979) Human ß-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature. 282: 210–212
Hunter WM (1977) Simplified solid-phase radioimmunoassay without centrifugation. Acta Endocrinol. 85: 463
Ikeda T, Nonaka Y, Goto A, Ishii M (1985) Effects of praxosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension. Clin Pharmacol. 37: 601–605
Jaffe EA, Leung LLK, Nachman RL, Levin RI, Mosher DF (1982) Thrombospondin is the endogenous lectin of human platelets. Nature. 295: 246–248
Janka HU, Standi E, Schramm W, Mehnert H (1983) Platelet enzyme activities in diabetes mellitus in relation to endothelial damage Diabetes. 32: 47–51
Kahaleh MB, Osborn I, Leroy EC (1982) Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Ann Intern Med. 96: 610–613
Kaplan KL, Niewiarowski S (1985) Nomenclature of secreted platelet proteins - report of the working party on secreted platelet proteins of the subcommittee on platelets. Thromb Haemost. 53: 282–284
Kaplan KL, Owen J (1981) Plasma levels of ß-thromboglobulin and PF4 as indexes of platelet activation in vivo. Blood. 57: 199–202
Kaplan KL, Owen J (1982) Radioimmunoassay of ß-thromboglobulin. Methods Enzymol. 84: 93–102
Kaplan KL, Nossel HL, Drillings M, Lesznik G (1978) Radioimmunoassay of platelet factor 4 and ß-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol. 39: 129–146
Kerry PJ, Curtis AD (1985) Standardisation of ß-thromboglobulin (ß-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for ß-TG and PF4. Thromb Haemost. 53: 51–55
Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P (1983) Increased beta-thromboglobulin in essential hypertension - interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand. 213: 369–373
Kordenat K, Dawes J, Pepper DS (1983) Canine thrombospondin (TSP) levels measured in plasma by radioimmunoassay before and during acute coronary thrombosis. Thromb Haemost. 49: 250
Lane DA, Ireland H, WolffS, Ranasinghe E, Dawes J (1984) Detection of enhanced in vivo platelet a-granule release in different patient groups - comparison of ß-thromboglobu- lin, platelet factor 4 and thrombospondin assays. Thromb Haemost. 52: 183–187
Lawler JW (1981) Prediction of the secondary structure of platelet factor 4 and ß-throm-boglobulin from their amino acid sequences. Thromb Res. 21: 121–127
Lawler JW, Slayter HS, Coligan JE (1978) Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem. 253: 8609–8616
Levine SP, Krentz LS (1977) Development of a radioimmunoassay for human platelet factor 4. Thromb Res. 11: 673–686
Levine SP, Lindenfeld J, Crawford M, Horwitz LD (1979) Effects of catecholamines on plasma platelet factor 4 in normal human subjects. Clin Res. 27: A462
Levine SP, Suarez AJ, Sorenson RR, Knieriem LK, Raymond NM (1981 a) The importance of blood collection methods for assessment of platelet activation. Thromb Res. 24: 433–443
Levine PH, Fisher M, Fullerton AL, Duffy CP, Hoogasian JJ (1981 b) Human platelet factor 4 - preparation from outdated platelet concentrates and application in cerebral vascular disease. Am J Haematol. 10: 375–385
Levine SP, Knieriem LK, Harris MA, George JN (1982) Emotional stress, catecholamines (CATS) and platelet activation. Circulation. 66: 52
Levine SP, Suarez AJ, Sorenson RR, Raymond NM, Knieriem LK (1984) Platelet factor 4 release during exercise in patients with coronary artery disease. Am J Haematol. 17: 117–127
Levine SP, Towell BL, Suarez AM, Knieriem LK, Harris MM, George JN (1985) Platelet activation and secretion associated with emotional stress. Circulation. 71: 1129–1134
Longenecker GL, Bowen RJ, Swift I A, Beyers BJ (1984) Increased beta-thromboglobulin in the serum of smokers occurs because of increased platelet counts. Res Commun Sub Abuse. 5: 147–152
Longo G, Cecchi F, Grossi A, Matucci M, Rafanelli D, Vannucchi AM, Casprini P, Mor- fini M, Dolara A (1984) Coagulation and platelet function in hypertrophic cardiomyopathy. Thromb Haemost. 51: 299
Ludlam CA, Cash JD (1976) Studies on the liberation of ß-thromboglobulin from human platelets in vitro. Br J Haematol. 33: 239–247
Ludlam CA, Allan N, Blandford RB, Dowdle R, Bentley NJ, Bloom AL (1981) Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphin- pyrazone. Thromb Haemost. 46: 743–746
Luscombe M, Marshall SE, Pepper DS, Holbrook JJ (1981) The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymers. Biochim Biophys Acta. 678: 137–142
Luster AD, Unkeless JC, Ravetch JV (1985) y-Interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature. 315: 672–676
Manotti C, Quintavalla R, Manzoni GC (1983) Platelet activation in migraine. Thromb Haemost. 50: 758
Mant MJ, Kappagoda CT, Taylor RF, Quinlan JE (1984) Platelet activation caused by cardiac catheter blood collection and its prevention. Thromb Res. 33: 177–187
Margossian SS, Lawler JW, Slayter HS (1981) Physical characterisation of platelet throm- bospondin. J Biol Chem. 256: 7495–7500
McPherson J, Sage H, Bornstein P (1981) Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombo- spondin. J Biol Chem. 256: 11330–11336
Messmore HL, Walenga JM, Fareed J (1984) Molecular markers of platelet activation. Semin Thromb Hemost. 10:264 –269
Moore S, Pepper DS, Cash JD (1975 a) Platelet antiheparin activity: the isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane bound antiheparin activity. Biochim Biophys Acta. 379: 370–384
Moore S, Pepper DS, Cash JD (1975 b) The isolation and characterisation of a platelet spe-cific ß-globulin (ß-thromboglobulin) and the detection of anti-urokinase and antiplas- min released from thrombin aggregated washed human platelets. Biochim Biophys Acta. 379: 360–369
Mosher DF, Doyle MJ, Jaffe EA (1982) Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol. 93: 343–348
Motomiya T, Yamazaki H (1981) Plasma ß-thromboglobulin and platelet factor 4 during the normal menstrual cycle. Acta Haematol Jpn. 44: 193–195
Muggli R, Glatthaar B, Mittelholzer E, Tschopp TB (1981) Purification, characterization and radioimmunoassay of a new antiheparin protein secreted by rabbit platelets. Thromb Haemost. 46: 20
Muhlhauser I, Schernthaner G, Silberbauer K, Sinzinger H, Kaliman J (1980) Platelet proteins (Beta-TG and PF4) in atherosclerosis and related diseases. Artery. 8: 73–79
Muhlhauser I, Schernthaner G, Silberbauer K, Sinzinger H, Kaindl F (1981) Plasma concentrations of platelet specific proteins in coronary artery disease. Cardiology. 68:129– 138
Najean Y, Poirier O (1984) Beta-thromboglobulin and platelet factor 4 in polycythemia patients treated by ticlopidine. Acta Haematol. 72: 83–89
Niewiarowski S, Poplawski A, Lipinski B, Farbiszewski R (1968) The release of platelet clotting factors during aggregation and viscous metamorphosis. Exp Biol Med. 3: 121–128
O’Brien JR, Etherington MD, Pashley M (1984) Intra-platelet platelet factor 4 (IP.PF4) and the heparin mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost. 51: 354–357
Phillips DR, Jennings LK, Prasanna HR (1980) Ca2 + mediated association of glycoprotein G (thrombin-sensitive protein, thrombospondin) with human platelets. J Biol Chem. 255: 11629–11632
Pogliani EM, Colombi M, Cristoforetti G, Valenti G, Miradoli R, Buccianti G (1982) Beta- thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of in- dobufen. Pharmatherapeutica. 3: 127–132
Porta M, Peters AM, Cousins SA, Cagliero E, Fitzpatrick ML, Kohner EM (1983) A study of platelet relevant parameters in patients with diabetic micro-angiopathy. Diabetalo- gia. 25: 21–25
Prowse C, Pepper DS, Dawes J (1982) Prevention of the platelet alpha-granule release reaction by membrane active drugs. Thromb Res. 25: 219–227
Rasi V (1979) Beta-thromboglobulin in plasma - false high values caused by platelet enrichment of the top layer of plasma during centrifugation. Thromb Res. 15: 543–552
Reynders J, Rodzynek J J, Leautaud P, Delcourt A (1984) Comparison between platelet function tests in diabetic patients with special reference to beta-thromboglobulin. Acta Clin Belg. 39: 314
Riess H, Hiller E, Reinhardt B, Brauning C (1984) Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease. Thromb Res. 35: 371–378
Rosove MH, Frank HJL, Haewig SSL (1984) Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Diabetes Care. 7: 174–179
Rucinski B, Poggi A, James P, Holt JC, Niewiarowski S (1983) Purification of 2 heparin binding proteins from porcine platelets and their homology with human secreted platelet proteins. Blood. 61: 1072–1080
Saglio SD, Slayter HS (1982) Use of a radioimmunoassay to quantify thrombospondin. Blood. 59: 162–166
Salter MCP, Crow MJ, Learoyd P, Rajah SM (1982) Platelet function and survival changes before and after coronary artery revascularisation: assessment of the influence of dipyridamole and acetylsalicylic acid. Haemostasis. 12: 191
Sano T, Motomiya T, Yamazaki H (1980) Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole. Thromb Haemost. 42: 1589–1597
Schernthaner G, Muhlhauser I, Silberbauer K (1979) ß-Thromboglobulin lowered by dipyridamole in diabetes. Lancet. 11: 748–749
Schmidt KG, Rasmussen JW (1984) Acute platelet activation induced by smoking: in vivo and ex vivo studies in humans. Thromb Haemost. 51: 279–282
Semple MJ, Al-Hasani SF, Kioy P, Savidge GF (1984) A double-blind trial of ticlopidine in sickle cell disease. Thromb Haemost. 51: 303–306
Simi M, Leardi S, Castelli M, Tebano MT, Vitale M, Prantera C, Speranza V (1982) Plasmatic levels of platelet factor 4 (PF4) in Crohn’s disease. World J Surg. 6: 662
Sinzinger H, Horsch AK, Silberbauer K (1983) The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease. Thromb Haemost. 50: 885–887
Smith RC, Duncanson J, Ruckley CV, Webber RG, Allan NC, Dawes J, Bolton AE, Hunter WM, Pepper DS, Cash JD (1978) ß-Thromboglobulin and deep vein thrombosis. Thromb Haemost. 39: 338–345
Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G (1981) Circulating platelet products in unstable angina-pectoris. Circulation. 63: 300–306
Steele PP (1980) Platelet suppressants inhibit release of beta-thromboglobulin during isometric exercise in coronary disease. Clin Res. 28: A214
Strano A, Davi G (1982) Platelet release reaction, platelet sensitivity to prostacyclin and thromboxane production by platelets in hyperlipidemia. Haemostasis. 12: 87
Suarez AJ, Levine SP, George JN (1982) Emotional stress, catecholamines and platelet activation. Clin Res. 30: A331
Taomoto K, Asada M, Kanazawa Y, Matsumoto S (1983) Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease. Stroke. 14: 518–524
Turpie AGG, Gent M, DeBoer AC, Giroux M, Kinch D, Butt R, Gunstensen J, Saerens E, Genton E (1984) Effect of suloctidil on platelet function in patients with shortened platelet survival time. Thromb Res. 35: 397–406
Valles J, Aznar J, Santos MT (1982) Relationship between platelet fatty acid pattern and plasma ß thromboglobulin. Thromb Res. 27: 737–742
Van Hulsteijn H, Fibbe W, Bertina R, Briet E (1982) Plasma fibrinopeptide A and beta- thromboglobulin in major bacterial infections. Thromb Haemost. 48: 247–249
Van Hulsteijn H, Kolff J, Briet E, Vanderlaarse A, Bertina R (1984) Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. Am Heart J. 107: 39–5
Van Oost BA, Veldhuyzen B, Timmermans APM, Sixma JJ (1983) Increased urinary ß- thromboglobulin excretion in diabetes assayed with a modified RIA kit-technique. Thromb Haemost. 49: 18–20
Viero P, Cortelazzo S, Barbui T (1984) Does the ß-TG/PF4 ratio have any value in myeloproliferative diseases? Thromb Haemost. 51: 411
Violi F, Juliano L, Alessandri C, Frattaroli S, Bonavita MS (1984) Beta-thromboglobulin plasma levels in common migraine. Thromb Haemost. 51: 295
Walker ID, Davidson JF, Faichney A, Wheatley DJ, Davidson KG (1981) A double blind study of prostacyclin in cardiopulmonary bypass surgery. Br J Haematol. 49: 415–423
Walz DA (1984) Platelet released proteins as molecular markers for the activation process. Semin Thromb Hemost. 10:270–279
Wight TN, Raugi GJ, Mumby SM, Bornstein P (1985) Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem. 33: 295–302
Wojciechowski J, Olausson M, Korsanbengtsen K (1983) Fibrinopeptide A, beta-throm- boglobulin and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis. Haemostasis. 13: 254–261
Woodhams BJ, Kernoff PBA (1983) The application of polyethylene glycol to radioimmunoassays used in haemostasis. Thromb Res. 29: 333–341
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pepper, D.S. (1987). Radioimmunoassay of Platelet Proteins. In: Patrono, C., Peskar, B.A. (eds) Radioimmunoassay in Basic and Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 82. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71809-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-71809-0_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71811-3
Online ISBN: 978-3-642-71809-0
eBook Packages: Springer Book Archive